Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,080 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07211269Recruiting
Brain training study for healthy volunteers
This study uses real-time brain scans (fMRI) to see how people's thinking skills affect their ability to learn to control their own brain activity. It is for healthy individuals who want to help researchers understand brain training.
Chengdu, ChengduAges 18–35 - NCT07204912Recruiting
Testing a brain-controlled leg prosthesis in real-world tasks
This trial tests a new powered leg prosthesis that you control with your own neural signals. It aims to help people with above-knee amputations walk more naturally in everyday situations.
Cambridge, MassachusettsAges 18–70 - NCT07206355Recruiting
Studying bile duct and liver lesions for new cancer tests
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
NottinghamAges 16 years+ - NCT06118788RecruitingPhase 1/Phase 2
BG1805 for relapsed or refractory acute myeloid leukemia
This trial tests a new treatment, BG1805, for people with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. It targets a specific marker on leukemia cells called CLL-1.
Guangzhou, GuangdongAges 18–70 - NCT06931275Recruiting
Reducing technology gaps in type 1 diabetes care
This trial tests if sending reminders to doctors can help more Black and Hispanic people with type 1 diabetes get access to helpful diabetes technology. It aims to reduce unfair differences in who gets to use these tools.
Boston, MassachusettsAges 2–95 - NCT06926348Recruiting
Testing a digital sleep aid for chronic insomnia
This study tests a digital sleep aid (a smartphone program) to see if it's easy to use and helps improve sleep. If you have chronic insomnia and own a compatible device, you may be able to join.
Verona, VeronaAges 18–70 - NCT06933914RecruitingPhase 2/Phase 3
Long-term safety of MY008211A for PNH
This study checks the long-term safety of the drug MY008211A for people with paroxysmal nocturnal hemoglobinuria (PNH). It is only for those who already took the drug in an earlier study and had benefit, and who have had specific vaccines.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07194265Recruiting
A study of the DurAVR heart valve for aortic stenosis
This trial tests a new heart valve called DurAVR for people with severe aortic stenosis (a narrowed aortic valve) who need a valve replacement. It compares the new valve to standard valves to see if it is safe and works well.
Copenhagen, Capital Region of DenmarkAges 18 years+ - NCT07195591RecruitingPhase 3
Starting radiation during brain cancer surgery vs. standard treatment
This trial tests putting radiation directly into the brain right after surgery for glioblastoma, instead of waiting for standard radiation later. It aims to see if this approach works better and is safe for you.
Scottsdale, ArizonaAges 18 years+ - NCT07193589RecruitingPhase 2
Testing ZL-82 tablets for moderate to severe eczema
This study tests if an oral tablet called ZL-82 can help people with moderate to severe atopic dermatitis (eczema) that hasn't responded well to other treatments. It aims to find a new option for controlling this chronic skin condition.
Chengdu, SichuanAges 18–75 - NCT06938373Recruiting
A test for breast cancer patients with possible depression
This study tests a new detection method for depression in people with breast cancer. It uses samples like blood, stool, and saliva to find a link between breast cancer and depression.
Changsha, HunanAges 18–80 - NCT06503224Recruiting
Cell therapy for refractory autoimmune diseases
This trial tests a new type of cell therapy (SCAR02) that targets two proteins on immune cells to help calm down overactive autoimmune diseases like rheumatoid arthritis, lupus, Sjögren's syndrome, or systemic sclerosis. It may be an option if standard treatments haven't worked well enough.
Changsha, HunanAges 18 years+ - NCT07188051Enrolling by invitation
Beauty from within hair, nail and skin trial
This trial tests a daily supplement to see if it helps improve facial wrinkles, sagging skin, hair growth, thickness, and nail strength. It could help people who are concerned about these signs of aging and want a natural approach.
Cincinnati, OhioAges 35–65 - NCT07191080Enrolling by invitation
Using advanced genetic testing to diagnose hard-to-find respiratory infections
This study uses a powerful genetic test (next-generation sequencing) to find the cause of respiratory infections when standard tests fail. It may help identify hard-to-detect viruses, bacteria, or fungi in your lung or airway samples.
Nantong, JiangsuAges 18 years+ - NCT07178080Enrolling by invitation
New 3D imaging for thyroid nodule measurement
This study compares a new 3D technology to standard ultrasound for measuring thyroid nodule volume. It may help doctors better track changes in nodules over time.
Sarasota, FloridaAges 22 years+ - NCT07177443RecruitingPhase 3
Immunotherapy with chemo and radiation for nasopharyngeal cancer
This trial tests a new immunotherapy drug (serplulimab) given together with standard chemotherapy and radiation for nasopharyngeal cancer that has spread to nearby lymph nodes. It aims to see if adding this drug can help shrink tumors and improve outcomes.
Wuhan, HubeiAges 18–65 - NCT07178054Recruiting
Measuring daily energy use in healthy Chinese adults
This study measures how much energy healthy people across China use each day by using a special water test. It helps researchers understand normal energy needs for different populations.
Chongqing, Chongqing MunicipalityAges 7–60 - NCT07174089Recruiting
New AI tools for nuclear medicine scans and treatments
This study uses artificial intelligence (AI) to improve PET/CT scans and treatments that use radioactive materials (radiopharmaceuticals) labeled with alpha or beta emitters. It may help doctors get better results from these procedures.
Reggio EmiliaAges 18–90 - NCT07165886RecruitingPhase 2/Phase 3
Study of sirolimus and octreotide for advanced neuroendocrine tumors
This trial tests a combination of two drugs, sirolimus and octreotide, for people with advanced neuroendocrine tumors in the digestive system that cannot be removed by surgery and are not making excess hormones. The goal is to see if this combination can help control the tumors.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07172360RecruitingPhase 3
Study of VC005 tablets for active ankylosing spondylitis
This trial tests a new tablet called VC005 to see if it helps reduce pain and stiffness in people with active ankylosing spondylitis. It's a phase 3 study, meaning it's one of the final steps before the drug may be approved for wider use.
Beijing, Beijing MunicipalityAges 18–70 - NCT07165951RecruitingPhase 3
Study of new drug combo for first treatment of advanced pancreatic cancer
This trial tests a new combination of drugs (TQB2868 injection plus anlotinib capsules) compared to standard chemotherapy for people with pancreatic cancer that has spread to other parts of the body and has not been treated before.
Hefei, AnhuiAges 18–75 - NCT07172347RecruitingPhase 2
VC005 tablets for non-segmental vitiligo
This trial tests an oral tablet called VC005 to see if it can help treat non-segmental vitiligo. It may be an option for adults with vitiligo patches that are not limited to one area of the body.
Beijing, BeijngAges 18–75 - NCT07174115RecruitingPhase 2
Testing a new tablet for chronic sinusitis without nasal polyps
This trial tests an experimental tablet (HTMC0658) for people with chronic sinusitis that hasn't improved with standard nasal spray. You may join if your symptoms are moderate to severe and you've been using a stable dose of mometasone spray for at least 4 weeks.
Luoyang, HenanAges 18–75 - NCT07172035Recruiting
TIPS and liver recovery in decompensated cirrhosis
This trial studies whether a procedure called TIPS (a stent placed in the liver to improve blood flow) can help people with advanced liver disease regain better liver function. It is for patients who have had complications like severe bleeding from the stomach or difficult-to-control fluid buildup (ascites).
ChangshaAges 18–80
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,080 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.